Ayako Shimada
Overview
Explore the profile of Ayako Shimada including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
389
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Setty B, Maddipati K, Keith S, Shimada A, Sheerer P, Miller R
Prostaglandins Leukot Essent Fatty Acids
. 2025 Mar;
205:102670.
PMID: 40036911
Oxylipins are polyunsaturated fatty acid (PUFA)-derived inflammatory mediators, and include both pro-inflammatory (prostaglandins, thromboxane, leukotrienes), and pro-resolving (lipoxins, E-resolvins, D-resolvins, protectins, maresins) molecules. Sickle cell disease (SCD) is an inflammatory...
2.
Shimada A, Ohnaka S, Nakashima M, Nagai A
Cureus
. 2025 Jan;
16(12):e75909.
PMID: 39830565
Gastrointestinal (GI) metastases from lung cancer are relatively rare, and their management strategies and outcomes in the era of immune checkpoint inhibitors are unknown. A 59-year-old man with lung cancer...
3.
Suzuki Y, Kawasaki T, Tatsumi K, Okaya T, Sato S, Shimada A, et al.
Int J Mol Sci
. 2024 Dec;
25(23).
PMID: 39684311
In hypoxic pulmonary hypertension (PH), pulmonary vascular remodeling is characterized by the emergence of activated adventitial fibroblasts, leading to medial smooth muscle hyperplasia. Previous studies have suggested that CD26/dipeptidyl peptidase-4...
4.
Partridge A, Hyslop T, Rosenberg S, Bennett A, Drier S, Jonsson M, et al.
JAMA Oncol
. 2024 Dec;
PMID: 39665588
Importance: Active monitoring (AM) for low-risk ductal carcinoma in situ (DCIS) has been considered as a potential alternative to guideline-concordant care (GCC; inclusive of surgery with or without radiation). Reported...
5.
Hwang E, Hyslop T, Lynch T, Ryser M, Weiss A, Wolf A, et al.
JAMA
. 2024 Dec;
PMID: 39665585
Importance: Active monitoring for low-risk ductal carcinoma in situ (DCIS) of the breast has been proposed as an alternative to guideline-concordant care, but the safety of this approach is unknown....
6.
Mori M, Ii H, Fujita M, Nose K, Shimada A, Shiraki R, et al.
Cancer Genomics Proteomics
. 2024 Aug;
21(5):474-484.
PMID: 39191500
Background/aim: Glioblastoma is the most frequent type of adult-onset malignant brain tumor and has a very poor prognosis. Glioblastoma stem cells have been shown to be one of the mechanisms...
7.
Zhou X, Ye C, Okamoto T, Iwao Y, Kawata N, Shimada A, et al.
Jpn J Radiol
. 2024 Aug;
42(12):1425-1438.
PMID: 39096482
Purpose: Chronic obstructive pulmonary disease (COPD), characterized by airflow limitation and breathing difficulty, is usually caused by prolonged inhalation of toxic substances or long-term smoking habits. Some abnormal features of...
8.
Myers R, Hallman M, Shimada A, DiCarlo M, Davis K, Leach W, et al.
Cancer Med
. 2024 May;
13(10):e7312.
PMID: 38785202
Introduction: Clinical trials are being conducted and are being planned to assess the safety and efficacy of multi-cancer early detection (MCED) tests for use in cancer screening. This study aimed...
9.
Ohno T, Shimada A, Terada Y, Ito T, Miyamoto K
Cureus
. 2024 Jan;
15(12):e51101.
PMID: 38274918
Relapsing polychondritis is a rare disease that causes progressive and recurrent destruction of cartilage in the auricles, eyes, nose, and airways. A 90-year-old man was brought to the emergency department...
10.
Myers R, Hallman M, Shimada A, Dicarlo M, Davis K, Leach W, et al.
J Pers Med
. 2023 Nov;
13(11).
PMID: 38003928
Multi-cancer early detection (MCED) tests are being developed, but little is known about patient receptivity to their use for cancer screening. The current study assessed patient interest in such testing....